Expert Consensus on Nutrition Standards for Intensive Care Units in Resource Limited Settings

November 14, 2026 updated by: Vijay Sundarsingh, RESQ Nutri ICU group

International Consensus on Nutritional Practices in Resource-Limited Intensive Care Units: The RES-Q Nutri ICU (REsource-limited Standards & Quality for Nutrition in the ICU) Modified Delphi Consensus Study

The goal of this observational study is to develop practical, expert-agreed standards for nutrition care of critically ill adults in intensive care units (ICUs) in resource-limited settings. The main question it aims to answer is:

Which nutrition practices do international ICU experts agree are essential and achievable for critically ill patients in hospitals with limited resources?

Participants will be ICU doctors, dietitians and nurses with experience of nutrition care in resource-limited settings. They will rate a set of statements across five areas of ICU nutrition in anonymous online survey rounds. After each round they will see a summary of the group's responses and may revise their ratings. A statement reaches agreement when at least 80% of experts agree with it, and rounds will continue until responses stabilise. ICU survivors and family members will also review a plain-language version of the statements, and their feedback will be shared with the expert panel.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Background: International ICU nutrition guidelines come almost entirely from trials in high-income settings. Lower-middle-income countries contributed less than 1% of patients and low-income countries none. ICUs that lack dietitians, feeding pumps, indirect calorimetry, post-pyloric access, specialised formulas or laboratory monitoring have no agreed minimum standard. This includes ICUs in low- and middle-income countries, remote or public facilities anywhere, and ICUs during surges. "Resource-limited" here is defined by what resources are available, not by World Bank income group.

Design: This is an international, web-based modified Delphi study reported according to ACCORD. A multidisciplinary Steering Committee drafts and refines the statements and analyses responses but does not vote. An independent Delphi methodologist oversees the process to limit bias. Panellists are recruited by purposive sampling through professional networks and societies, aiming for diversity in profession, geography, sex and resource setting.

Statement development: Round 1 statements come from a systematic search of PubMed, Embase, Scopus, Web of Science, Google Scholar and ESPEN, ASPEN and ESICM guidelines, covering adult literature in English from 2015 to 2026. Two reviewers screen in Rayyan and report selection in a PRISMA diagram. Statements are grouped into five domains: screening and assessment; timing, route and delivery; monitoring and metabolic control; micronutrients and special situations; and team, documentation and quality improvement. An evidence summary goes out with Round 1.

Delphi process: Panellists will rate statements on a 9-point scale, give free-text comments and describe the resource limitations in their practice. In later rounds they receive their own previous rating, the group median and IQR, percentage agreement and anonymised comments. A statement is revised when at least 10% of respondents (at least four) raise the same issue, and revisions that change its meaning are re-rated. Rounds continue until responses are stable, and the panel then approves the final set.

Patient involvement: Five to ten ICU survivors or patient representatives take part in single interviews in their preferred language and rate the value of the Round 1 statements. Their views are fed back to the panel but do not count towards consensus.

Analysis: Consensus to include is at least 80% of ratings at 7-9, and consensus to exclude is at least 80% at 1-3. Stability is tested with the Wilcoxon signed-rank test between consecutive rounds. If attrition exceeds 20%, a sensitivity analysis is run. Exploratory comparisons are made by profession and by income setting.

Ethics: Approved by the Institutional Ethics Committee, Father Muller Medical College (FMIEC/CCM/495/2026), with electronic consent from panellists.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Karnataka
      • Mangalore, Karnataka, India, 575002
        • Father Muller Medical College
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population is an international, multidisciplinary panel of about 40 to 50 professionals with expertise in adult critical care nutrition practice, research, education or guideline development. It includes intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers and allied professionals involved in ICU nutrition. At least 60% of the panel will be from low- and middle-income countries or will have current experience of working in resource-limited ICUs, and at least one-third will be non-physicians. In addition, 5 to 10 adult ICU survivors or patient-care representatives, mainly from resource-limited settings, will take part in patient and public involvement interviews.

Description

Inclusion Criteria:

  • Panellists will be eligible if they meet all of the following criteria:

    1. Professional background: Adult ICU clinicians or researchers involved in critical care nutrition practice, research, education, or guideline development, and belonging to one of the following professional groups: intensivists, ICU dietitians, critical care nurses, clinical pharmacists, nutrition researchers, or allied professionals involved in ICU nutrition.

    2. Relevant expertise: At least one of the following:

      1. At least one peer-reviewed publication related to critical care nutrition.
      2. A minimum of 10 years of relevant ICU or nutrition experience, with at least 50% of clinical time spent managing critically ill patients.
      3. Involvement in nutrition guideline or protocol development.
      4. A leadership or advocacy role in a critical care or nutrition society; or
      5. At least 5 years of direct experience working in resource-limited ICU settings.
    3. Willingness to participate: Willingness to participate in multiple Delphi rounds.

    4. Professional diversity: At least one-third of the final panel will comprise non-physicians.

Exclusion Criteria:

  • 1. Failure to provide implied consent through survey participation. 2. Inability to comprehend or independently vote on statements written in English. (To support non-native English speakers, all Delphi statements will be written in clear, unambiguous English.) 3. Incomplete Round 1 response with no rating data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Expert Delphi Panel

International multidisciplinary panel of approximately 40 to 50 experts in adult critical care nutrition, including intensivists, ICU dietitians, critical care nurses, clinical pharmacists and nutrition researchers.At least 60% will be from low- and middle-income countries or resource-limited ICUs, and at least one-third will be non-physicians. Panellists will rate draft statements on minimum nutrition standards over iterative anonymous online rounds until consensus and stability are reached.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To establish consensus-based minimum standards for assessment, initiation, delivery, and monitoring of nutritional therapy in resource-limited ICUs.
Time Frame: Through study completion, an average of 18 months

Number and proportion of Delphi statements reaching consensus to include (at least 80% of panellists rating 7 to 9 on a 9-point Likert scale) or consensus to exclude (at least 80% rating 1 to 3), with response stability between consecutive rounds (no significant variation on the Wilcoxon signed-rank or Kruskal-Wallis test, p of 0.05 or more). For each statement, the median, interquartile range and percentage agreement will be reported.

Through study completion, an average of 18 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To identify pragmatic adaptations of existing international ICU nutrition guidelines for resource-limited settings.
Time Frame: Through study completion, an average of 18 months

Number and proportion of statements describing adaptations of ESPEN, ASPEN or ESICM recommendations that reach consensus to include (at least 80% rating 7 to 9) with response stability.

Through study completion, an average of 18 months
To identify essential (minimum) nutritional practices for critically ill patients in ICUs
Time Frame: Through study completion, an average of 18 months

Number and proportion of statements rated "essential" (7 to 9) by at least 80% of panellists with response stability, reported for each of the five domains.

Through study completion, an average of 18 months
To identify research priorities in ICU nutrition for resource-limited settings.
Time Frame: Through study completion, an average of 18 months

Research priorities identified from statements reaching no consensus after repeated rating, and from themes in panellists' free-text comments, analysed thematically.

Through study completion, an average of 18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Vijay Sundarsingh, MD,DM, Father Muller Medical College
  • Principal Investigator: Soumaya Touzani, MD, PhD, Hassan II University Hospital
  • Principal Investigator: Prashant Nasa, MD,FNB, University Hospital Plymouth NHS Trust, Plymouth, UK

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

June 30, 2028

Study Registration Dates

First Submitted

November 9, 2026

First Submitted That Met QC Criteria

November 14, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 14, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • FMIEC/CCM/495/2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. Participants consented to their responses being reported only in aggregate, and the small expert panel carries a risk of re-identification. Aggregate results for each statement will be published in the final manuscript.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.